Work

Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL–transformed hematopoietic cell lines

Year: 2000

Type: article

Source: Blood

DOI: 10.1182/blood.v95.11.3498

Authors: Ellen Weisberg, James D. Griffin

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: American Society of Hematology

OpenAlex ID: W2263837564

FWCI: 33.1

Cites: 42

Cited by: 402

Related to: 7